ilube 5 %w/v eye drops solution
moorfields eye hospital nhs foundation trust - acetylcysteine - eye drops solution - 5 %w/v - other ophthalmologicals
dropodex 0.1% w/v eye drops, solution
moorfields eye hospital nhs foundation trust t/a moorfields pharmaceuticals - dexamethasone phosphate 1 mg/ml - eye drops, solution
bimtop bimatoprost 300 microgram/ml eye drop bottle
viatris pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops - excipient ingredients: sodium hydroxide; hydrochloric acid; dibasic sodium phosphate; benzalkonium chloride; citric acid monohydrate; water for injections; sodium chloride - bimtop is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.
ilevro nepafenac 0.3% eye drops, suspension, bottle
novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.
paladopt olopatadine (as hydrochloride) 1 mg/ml eye drop bottle
viatris pty ltd - olopatadine hydrochloride, quantity: 1.11 mg/ml (equivalent: olopatadine, qty 1 mg/ml) - eye drops - excipient ingredients: sodium hydroxide; water for injections; dibasic sodium phosphate; benzalkonium chloride; sodium chloride; hydrochloric acid - for the treatment of the signs and symptoms of seasonal allergic conjunctivitis. treatment may be maintained for up to 14 weeks, if considered necessary.
eye heat therapy pack
designs for vision aust pty ltd - 61023 - eye heat therapy pack - a reusable hot and cold pack for relief of symptoms associated with dry eye disease.
simbrinza 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle
novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction
cosdor dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop bottle
viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: mannitol; benzalkonium chloride; hyetellose; water for injections; sodium citrate dihydrate; sodium hydroxide - cosdor is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
xalaprost latanoprost 50 microgram/ml eye drops bottle
viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
xalamol 50/5 latanoprost 50 microgram/ml + timolol (as maleate) 5 mg/ml eye drops bottle
viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; water for injections; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalamol 50/5 should not be used to initiate therapy.